Abstract
The abstract for this article is not available.
Keywords: drug resistance, apoptosis, senescence, mitotic catastrophe, neiosis, non-receptor serine, atp binding site, protein kinase selectivity, sti-571, bms-354825
Current Medicinal Chemistry - Anti-Cancer Agents
Title: Tumor Cell Resistance to DNA-Damaging Agents: From Apoptosis to Neiosis
Volume: 4 Issue: 5
Author(s): Francois Martin and Eric Solary
Affiliation:
Keywords: drug resistance, apoptosis, senescence, mitotic catastrophe, neiosis, non-receptor serine, atp binding site, protein kinase selectivity, sti-571, bms-354825
Abstract: The abstract for this article is not available.
Export Options
About this article
Cite this article as:
Martin Francois and Solary Eric, Tumor Cell Resistance to DNA-Damaging Agents: From Apoptosis to Neiosis, Current Medicinal Chemistry - Anti-Cancer Agents 2004; 4 (5) . https://dx.doi.org/10.2174/1568011043352768
DOI https://dx.doi.org/10.2174/1568011043352768 |
Print ISSN 1568-0118 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5968 |
Related Articles
-
Heart Disease in Patients with HIV/AIDS-An Emerging Clinical Problem
Current Cardiology Reviews Molecular Treatment of Different Breast Cancers
Anti-Cancer Agents in Medicinal Chemistry Colon Adenocarcinoma Multidrug Resistance Reverted by Euphorbia Diterpenes: Structure-Activity Relationships and Pharmacophore Modeling
Anti-Cancer Agents in Medicinal Chemistry Interactions of the Aryl Hydrocarbon Receptor with Inflammatory Mediators:Beyond CYP1A Regulation
Current Drug Metabolism A Synopsis on the Role of Human Papilloma Virus Infection in Cervical Cancer
Current Drug Metabolism Nanotechnology, A Tool for Diagnostics and Treatment of Cancer
Current Topics in Medicinal Chemistry Functional Evaluation of an Ectopic Supernumerary Kidney in Pelvis
Current Medical Imaging Tyrosine Kinases as Molecular Targets to Inhibit Cancer Progression and Metastasis
Current Pharmaceutical Design Bone Disease - Current Knowledge and Future Prospects
Current Genomics Epigenetic Modifications as Therapeutic Targets
Current Drug Targets Simple Stereoselective Synthesis of Unsaturated Lactone Intermediates and Their Conversion into Natural Dihydropyranones and Their Enantiomers#
Letters in Organic Chemistry From Bortezomib to other Inhibitors of the Proteasome and Beyond
Current Pharmaceutical Design Cell Arrest and Apoptosis Induced by the Next Generation of Vanadium Based Drugs: Action Mechanism to Structure Relation and Future Perspectives
Anti-Cancer Agents in Medicinal Chemistry The PKB/AKT Pathway in Cancer
Current Pharmaceutical Design Role of Flavonoids in Future Anticancer Therapy by Eliminating the Cancer Stem Cells
Current Stem Cell Research & Therapy Approaching the Increasing Complexity of Non-small Cell Lung Cancer Taxonomy
Current Pharmaceutical Design Effect and Mechanism of Curcumin on EZH2 - miR-101 Regulatory Feedback Loop in Multiple Myeloma
Current Pharmaceutical Design Looking at Drug Resistance Mechanisms for Microtubule Interacting Drugs: Does TUBB3 Work?
Current Cancer Drug Targets Inhibition of Transcription Factors by Plant-Derived Compounds and their Implications in Inflammation and Cancer
Current Pharmaceutical Design Editorial (Thematic Issue: Oncoviruses and Head and Neck Cancer: An Impending Facts)
Recent Patents on Biomarkers